Mobile Logo in White

Greehey CCRI Archives

Filter results


Kathryn Crouch (Aune Lab) Among the Winners at the Robert A. Clark Frontiers of Translational Science Research Day

May 21, 2021

  The Robert Clark Frontiers of Translational Science Research Day showcases posters that illustrate completed or ongoing research projects in Translational Science.  This year, due to current gathering restrictions, the event was hosted virtually …


Leibert Pub: Zebrafish Tumor Graft Transplantation to Grow Tumors In Vivo That Engraft Poorly as Single Cell Suspensions (Ignatius Lab)

May 21, 2021

Amanda Lipsitt, Nicole R. Hensch, Rodrigo Moreno-Campos, Kunal Baxi, Jiangfei Chen, Anil K. Challa, Eleanor Y. Chen, and Myron S. Ignatius Abstract Angiosarcoma is a clinically aggressive tumor with a high rate of mortality. It can arise in vascular or …


Current Exchange: CSHL’s COVID/SARS CoV2 Rapid Research Meeting Reports V (Gupta)

May 18, 2021

Excerpt from “CSHL’s COVID/SARS CoV2 Rapid Research Meeting Reports V” Structural biology, molecular biology, and immunology As with the previous two meetings, this one was broken up into sections by topic and the first up was “Host-virus Interactions/ …


Since 2004, UT Health San Antonio, Greehey Children’s Cancer Research Institute’s (Greehey CCRI) mission has been to advance scientific knowledge relevant to childhood cancer, contribute to the understanding of its causes, and accelerate the translation of knowledge into novel therapies. Through the discovery, development, and dissemination of new scientific knowledge, Greehey CCRI strives to have a national and global impact on childhood cancer. Our mission consists of three key areas: research, clinical, and education.

Stay connected with the Greehey CCRI on Facebook, Twitter, LinkedIn, and Instagram.

NIH Grant Awarded to Collaborative Team to Eradicate Ewing Sarcoma (Aune)

May 13, 2021

Despite the breakthroughs being made in treating many cancers with less toxic, targeted, and immune-based therapies, Ewing sarcoma’s 40-year-old chemotherapy regimen remains a significant contributor to mortality and long-term cardiovascular complicati …


Yogesh Gupta,PhD., Invited to Present at Advanced Photon Source of Argonne National Laboratory, COVID-19 Workshop

May 13, 2021

Recently, Greehey CCRI principal investigator, Yogesh Gupta, PhD., was included as an invited speaker with prominent scientists from academia (Ian Wilson, Pamela Bjorkman, and others) and industry (Pfizer and Moderna) at a COVID-19 workshop organized b …


BMC Bioinformatics: CancerSiamese: one-shot learning for predicting primary and metastatic tumor types unseen during model training (Chen Lab)

May 13, 2021

Milad Mostavi, Yu-Chiao Chiu, Yidong Chen & Yufei Huang Abstract Background The state-of-the-art deep learning-based cancer type prediction can only predict cancer types whose samples are available during the training where the sample size is commo …


Journal of Clinical Medicine: Recent Developments in Nanomedicine for Pediatric Cancer (Kurmasheva)

April 30, 2021

by  Shicheng Yang 1, Mia Wallach 2 , Apurva Krishna 3, Raushan Kurmasheva 4,5,*,†  and Srinivas Sridhar 1,3,6,*,† Abstract Cancer is the second biggest cause of death in children in the US. With the development of chemotherapy, there has been a substan …


International Journal of Molecular Sciences: A Comprehensive Analysis into the Therapeutic Application of Natural Products as SIRT6 Modulators in Alzheimer’s Disease, Aging, Cancer, Inflammation, and Diabetes (Rao Lab)

April 30, 2021

Raushanara Akter 1, Afrina Afrose 1, Md Rashidur Rahman 2, Rakhi Chowdhury 1, Saif Shahriar Rahman Nirzhor 3, Rubayat Islam Khan 4, Md Tanvir Kabir 1 ABSTRACT Natural products have long been used as drugs to treat a wide array of human diseases. The le …


JCM: Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children’s Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force (Houghton)

April 30, 2021

by  Holly L. Pacenta 1,2, Wendy Allen-Rhoades,  3, David Langenau,  4, Peter J. Houghton,  5, Charles Keller 6, Christine M. Heske,  7 , Michael D. Deel,  8, Corinne M. Linardic,  8 , Jack F. Shern 7, Elizabeth Stewart,  9, Brian Turpin,  10, Douglas J …


Since 2004, UT Health San Antonio, Greehey Children’s Cancer Research Institute’s (Greehey CCRI) mission has been to advance scientific knowledge relevant to childhood cancer, contribute to the understanding of its causes, and accelerate the translation of knowledge into novel therapies. Through the discovery, development, and dissemination of new scientific knowledge, Greehey CCRI strives to have a national and global impact on childhood cancer. Our mission consists of three key areas: research, clinical, and education.

Stay connected with the Greehey CCRI on Facebook, Twitter, LinkedIn, and Instagram.

A review article by Dr. Raushan Kurmasheva (senior author) gives an overview on recent developments in nanomedicine for pediatric cancer

April 30, 2021

Recent Developments in Nanomedicine for Pediatric Cancer by Shicheng Yang 1, Mia Wallach 2OrcID, Apurva Krishna 3, Raushan Kurmasheva 4,5,*,†OrcID and Srinivas Sridhar 1,3,6,*,† Abstract Cancer is the second biggest cause of death in children in the US …